Ethyl N-(6-((4-(4-Chloro-3-(trifluoromethyl)phenoxy)-3,5-difluorobenzyl)oxy)-3-methyl-2-oxo-2,3-dihydropyrimidin-4-yl)-Nmethylglycinate

ID: ALA3792774

Chembl Id: CHEMBL3792774

PubChem CID: 127053472

Max Phase: Preclinical

Molecular Formula: C24H21ClF5N3O5

Molecular Weight: 561.89

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)CN(C)c1cc(OCc2cc(F)c(Oc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)nc(=O)n1C

Standard InChI:  InChI=1S/C24H21ClF5N3O5/c1-4-36-21(34)11-32(2)20-10-19(31-23(35)33(20)3)37-12-13-7-17(26)22(18(27)8-13)38-14-5-6-16(25)15(9-14)24(28,29)30/h5-10H,4,11-12H2,1-3H3

Standard InChI Key:  YPMPMJSCBXLNPC-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3792774

    ---

Associated Targets(Human)

PLA2G7 Tchem LDL-associated phospholipase A2 (1338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver (4264 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 561.89Molecular Weight (Monoisotopic): 561.1090AlogP: 5.10#Rotatable Bonds: 9
Polar Surface Area: 82.89Molecular Species: NEUTRALHBA: 8HBD: 0
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 5.14CX LogD: 5.14
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.27Np Likeness Score: -1.20

References

1. Chen X, Wang K, Xu W, Ma Q, Chen M, Du L, Mo M, Wang Y, Shen J..  (2016)  Discovery of Potent and Orally Active Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors as a Potential Therapy for Diabetic Macular Edema.,  59  (6): [PMID:26927682] [10.1021/acs.jmedchem.5b01930]

Source